Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

The Cephea transcatheter mitral valve in development has been acquired by Medtronic.

Abbott acquires another TMVR device through purchase of Cephea

Abbott plans to acquire Cephea Valve Technologies, a company developing a transcatheter mitral valve replacement (TMVR) device, the Chicago-area healthcare giant announced Jan. 16.

Thumbnail

Trendy ‘bone broth’ diets could have some cardiovascular merit

In the past year bone broth—the result of simmering animal bones with herbs and vegetables for anywhere between 20 minutes and 20 hours—has been lauded as a superfood, promoted as a Hollywood diet and linked to benefits like better gut health and stronger joints. Now, research out of Spain is proving at least some of those claims are true.

Thumbnail

Intensive statin doses offer no extra benefit for nursing home residents

Older adults living in long-term care facilities experienced a similar risk of mortality and cardiovascular hospitalizations regardless of whether they were taking intensive or more moderate doses of statins, a retrospective study found.

Thumbnail

Sleeping less than 6 hours a night could raise risk for atherosclerosis

Sleeping less than six hours a night or experiencing poor-quality rest has been independently linked to an increased risk of subclinical multiterritory atherosclerosis, a team of Spanish researchers reported in the Journal of the American College of Cardiology Jan. 14.

Thumbnail

New mobile app connects pacemakers to smartphones

Medtronic announced on Jan. 15 the launch of a mobile app that connects four of the company’s pacemakers to patients’ smartphones and tablets, removing the need for bedside monitors or other remote monitoring equipment.

Rivaroxaban doesn’t improve graft patency after CABG

Rivaroxaban failed to reduce the rate of early graft failure following coronary artery bypass graft (CABG) surgery compared to aspirin monotherapy, researchers reported in a substudy of the COMPASS trial published Jan. 14 in the Journal of the American College of Cardiology.

Thumbnail

Any amount of physical activity could cut risk of early death

A study published online in the American Journal of Epidemiology Jan. 14 suggests any physical movement, whether it’s short, long, intense or mild, counteracts the negative cardiovascular effects of sitting for long periods.

Thumbnail

PTSD—especially from terror attacks—has lasting cardiovascular consequences

Long-term sufferers of post-traumatic stress disorder (PTSD) are at a higher risk for circulatory and metabolic diseases, especially if they’re men, according to research out of Siena, Italy.